5-HT6 receptors as emerging targets for drug discovery

Citation
Ta. Branchek et Tp. Blackburn, 5-HT6 receptors as emerging targets for drug discovery, ANN R PHARM, 40, 2000, pp. 319-334
Citations number
63
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
ISSN journal
03621642 → ACNP
Volume
40
Year of publication
2000
Pages
319 - 334
Database
ISI
SICI code
0362-1642(2000)40:<319:5RAETF>2.0.ZU;2-Z
Abstract
5-ht(6) receptors are the latest serotonin receptors to be identified by mo lecular cloning. Their high affinity for a wide range of drugs used in psyc hiatry, coupled with their intriguing distribution in the brain, has stimul ated significant interest. Antisense oligonucleotides, antipeptide antibodi es, selective radioligands, knockout mice, and selective antagonists of the 5-ht(6) receptor have recently become available. Surprisingly, 5-ht(6) rec eptors appear to regulate cholinergic neurotransmission in the brain, rathe r than the expected interaction as modulators of dopaminergic transmission. This interaction predicts a possible role for 5-ht(6) receptor antagonists in the treatment of learning and memory disorders. Furthermore, polymorphi sms in the sequence of the 5-ht(6) receptor gene may provide a genetic tool to further our understanding of the differential responses of patients to antipsychotic medications.